souryashrestha.bsky.social
Infectious disease modeler | tuberculosis | pathogen interaction | global health | 🇳🇵| 🇺🇸
👤 Joined on 13 November 2024
Followers
Following
Total Posts
@souryashrestha.bsky.social3HP implementation is highly cost effective & should be scaled up nationwide to accelerate progress towards END TB goals. #UnionConference @johnshopkinssph.bsky.social @lstmnews.bsky.social (2/3)
Show PostOur colleague Anchal Thapa presenting at #Unionconference on ‘Impact & cost-effectiveness of implementing TB preventive treatment among adult household contact persons in Nepal: A model-based analysis’. @johnshopkinssph.bsky.social @lstmnews.bsky.social Highlights👇(Thread 1/3)
Show PostSome notes about TB prevention, as a former TB patient. TB is a bacterial disease. There is a vaccine, but it has variable efficacy & is not widely used in the U.S.. So, you can't make a "personal choice" (vaccine) to maximally protect yourself against this disease. So what protects you?
Show PostA huge part of teaching epidemiology is teaching how wrong the data could be, and how to make them less wrong (never right, there is always bias)
Show PostThis new guidance is yet another step closer towards an isolationist, diminished view of American science. Changing rules on the fly wastes time & effort and undermines the pipeline of discovery and innovation. Unacceptable & inexcusable (again): grants.nih.gov/grants/guide...
Show Post